Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetics (population and cerebrospinal fluid penetration) of gatifloxacin, levofloxacin, and ciprofloxacin in Vietnamese patients with tubercular meningitis.

Next Previous
Trial Profile

Pharmacokinetics (population and cerebrospinal fluid penetration) of gatifloxacin, levofloxacin, and ciprofloxacin in Vietnamese patients with tubercular meningitis.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Oct 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ciprofloxacin (Primary) ; Gatifloxacin (Primary) ; Levofloxacin (Primary) ; Ethambutol; Isoniazid; Pyrazinamide; Rifampicin
  • Indications Tubercular meningitis
  • Focus Biomarker; Pharmacokinetics; Therapeutic Use

Most Recent Events

  • 19 Oct 2011 New source identified and integrated (ISRCTN: Current Controlled Trials).
  • 19 Oct 2011 Additional trial centers identified as reported by ISRCTN.
  • 19 Oct 2011 Actual end date Feb 2005 added as reported by ISRCTN.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top